Physician profile
Aaron Michael Wolfson
NPI 1144584913
$15,672.05
in general payments reported to CMS, 2019-2025
19 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2021: $249 · 2022: $884 · 2023: $8,590 · 2024: $5,222 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,441.00 |
| Food and Beverage | $1,793.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $12,441.00 | 2023-2024 | |
| Abbott Laboratories | $1,329.72 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,102.94 | 2022-2025 | Impella |
| Impulse Dynamics (USA) INC. | $221.89 | 2022-2024 | Optimizer, Optimizer |
| W. L. Gore & Associates, INC. | $118.23 | 2019 | |
| Medtronic Vascular, INC. | $106.19 | 2019 | |
| Astellas Pharma US INC | $79.99 | 2019 | |
| Irhythm Technologies, INC. | $51.15 | 2022 | |
| Ancora Heart, INC. | $51.00 | 2023 | Accucinch |
| Baxter Healthcare | $46.28 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Scpharmaceuticals INC. | $34.91 | 2023 | |
| Cvrx, INC. | $30.93 | 2024 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.59 | 2025 | Lifevest |
| Cook Medical LLC | $16.16 | 2023 | Evolution |
| Alnylam Pharmaceuticals INC. | $16.07 | 2024 | Onpattro |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Wolfson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.